Physician profile
Megan E Temp
NPI 1063429421
$660.10
in general payments reported to CMS, 2019-2025
11 companies · $99.00 in 2025
The $99.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.38 · 2020: $12.50 · 2021: $108 · 2022: $219 · 2023: $144 · 2025: $99.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.94 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $226.15 | 2019-2023 | |
| Abbvie INC. | $109.80 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $99.00 | 2025 | |
| Therapeuticsmd, INC. | $38.88 | 2021 | |
| Sumitomo Pharma America, INC. | $37.66 | 2023 | Myfembree |
| Myovant Sciences INC. | $35.97 | 2022 | |
| Intuitive Surgical, INC. | $30.11 | 2022-2023 | Da Vinci Surgical System |
| Daiichi Sankyo INC. | $27.55 | 2022 | |
| Exeltis, USA INC. | $19.30 | 2022 | |
| Coopersurgical, INC. | $18.02 | 2023 | Supercut Hysterectomy Scissors |
| Roche Diagnostics Corporation | $17.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Temp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.